Threat Of Adulteration For Profit Grows With Globalization Of Supply Chain
This article was originally published in The Tan Sheet
Executive Summary
Deliberate adulteration of dietary supplements for economic gain is a growing threat that FDA and the food and drug industries must work together to neutralize, according to the agency's food safety chief and a trade group executive
You may also be interested in...
CDER Enforcement Priorities Include Quality Control, Drug "Criminalization"
FDA's Center for Drug Evaluation and Research will crack down on manufacturers that attempt to "farm out responsibility," firms that fail to meet reporting requirements and the general "criminalization of our drug supply," said Deb Autor, director of the center's compliance office
Country Of Origin Labeling Could Confuse Consumers, Increase OTC Costs
Country-of-origin labeling for drugs could drive OTC manufacturing costs up and confuse consumers with unnecessary information on labels, industry stakeholders say
Supplements Spared From Melamine “Bombs” – So Far, UNPA’s Israelsen Says
The dietary supplement industry has "been lucky," dodging a serious adulteration problem like the melamine contamination that has plagued pet food and infant formula businesses, Loren Israelsen says